Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2020-09-21

Clinical Trial Update: Effects and Safety of Metronidazole in Patients With Gastrectomy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating metronidazole in post-gastrectomy patients was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METRONIDAZOLE (Metronidazole)

Snippet

Sponsor: The Catholic University of Korea | Conditions: Post Gastrectomy State | Phase 3 | Status: WITHDRAWN